>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

SYNH +24.6%, AAXN +22.5%, ETSY +16.2%, OCN +14.2%, TIVO +12.9%, (also announces plan to explore all alternatives to maximize shareholder value), ENPH +11.1%,WTW +10.3%, TAST +9.3%, BKNG +8.4%, RRD +8.2%, FRAN +7.1%, MGIC +7%, CSU +6.6%, CGBD +6.5%, SBLK +6.1%, OAS +5.8%, ATSG +5.8%, VEEV +5.5%, CHS +5%, DAR+4.8%, RP +3.7%, MASI +3.4%, PNM +3.4%, HEI +3.1%, AKAO +3.1%, MTZ +3%, SUPN +3%, UNVR +3%, ATUS +2.8%, FSS +2.5%, UPL +2.4%, FRO +2%, IMAX +1.9%, ESRX+1.8%, RDC +1.8%, XOG +1.7%, DEPO +1.6%, STWD +1.6%, GBT +1.3%, WP +1.3%, MITT +1%, PEN +1%, ODP +1%, .

M&A news:

STB +24% (Student Transportation to be acquired by a group of investors led by CDPQ for US$7.50 per common share in cash)
PHH +23.7% (PHH Corp to be acquired by Ocwen (OCN) in an all cash transaction valued at $360 million, or $11.00 per fully-diluted share)
OCN +14.2% (PHH Corp to be acquired by Ocwen (OCN) in an all cash transaction valued at $360 million, or $11.00 per fully-diluted share)
SGYP +8.5% (acquires exclusive Canadian rights to FDA-Approved Trulance from Synergy Pharmaceuticals)
MON +0.9% (Monsanto merger with Bayer (BAYRY) said to be set to be approved by the EU, subject to conditions, according to Reuters)

Other news:

CODX +14.7% (positive results from Co-Primers Technology in multiplex test for SNP detection)
MTP +11.1% (European Medicines Agency has granted Orphan Drug Designation for its advanced liver cancer drug candidate MTD119)
HTBX +6.7% (announces 'positive' interim data from its Phase 2 clinical trial of HS-110 and Nivolumab in Non-Small Cell Lung Cancer)
MBVX +5.6% (reports positive safety results from initial cohort of MVT-1075 Radioimmunotherapy Phase 1 Trail for the treatment of Pancreatic, Colon and Lung Cancers)
ECYT +3.6% (proposed public offering of common stock)
EXPE +2.6% (following BKNG results)
NMIH +1.5% (prices 3.7 mln shares of common stock at $19.75 per share)
DPW +1.2% (reschedules investor webcast to March 15 at 5pm ET - originally set for February 21 - focus of the webcast will be on MTIX)
STMP +1% (hired former Mattel Chief Technology Officer Jonathan Bourgoine as its new Chief Technology Officer)
BEDU +1% (prices 10 mln ADS's at $19.00 per ADS)
SHPG +1% (receives FDA acceptance of BLA for Cal-PEG)
BIDU +0.8% (Baidu.com's iQiyi unit filed for $1.5 bln IPO late yesterday)

Analyst comments: